Chromosome 8 markers of metastatic prostate cancer in African American men: Gain of the MIR151 gene and loss of the NKX3-1 gene
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromosome 8 markers of metastatic prostate cancer in African American men: Gain of the MIR151 gene and loss of the NKX3-1 gene
Authors
Keywords
-
Journal
PROSTATE
Volume 71, Issue 8, Pages 857-871
Publisher
Wiley
Online
2010-11-18
DOI
10.1002/pros.21302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Homozygous Deletions and Recurrent Amplifications Implicate New Genes Involved in Prostate Cancer
- (2015) Wennuan Liu et al. NEOPLASIA
- Genomic Profiling of Prostate Cancers from African American Men
- (2015) Patricia Castro et al. NEOPLASIA
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy
- (2010) E. J. Whitman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- NKX3.1 Activates Cellular Response to DNA Damage
- (2010) C. Bowen et al. CANCER RESEARCH
- Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA
- (2010) Jie Ding et al. NATURE CELL BIOLOGY
- A Novel Prostate Cancer Susceptibility Locus at 19q13
- (2009) F.-C. Hsu et al. CANCER RESEARCH
- Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer
- (2009) A. T. El Gammal et al. CLINICAL CANCER RESEARCH
- Distinct genomic aberrations associated withERGrearranged prostate cancer
- (2009) Francesca Demichelis et al. GENES CHROMOSOMES & CANCER
- DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy
- (2009) Gunter Weiss et al. JOURNAL OF UROLOGY
- High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer
- (2009) Adrian S. Ishkanian et al. PROSTATE
- Recent Trends in Black-White Disparities in Cancer Mortality
- (2008) J. O. L. DeLancey et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis
- (2008) Cory Abate-Shen et al. DIFFERENTIATION
- The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24
- (2008) K. Huppi et al. MOLECULAR CANCER RESEARCH
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
- MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins
- (2008) S. Sengupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated levels of HER-2/neuand androgen receptor in clinically localized prostate cancer identifies metastatic potential
- (2008) Carmela Ricciardelli et al. PROSTATE
- Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer
- (2008) Robyn L. Prueitt et al. PROSTATE
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
- Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer
- (2003) J. Edwards et al. BJU INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started